Add over 300,000 shares on this dip, ADMD is stronger then ever. Remember, Heather Rosecrans is our Senior Consultant.
If you didn't pick up some shares on this pull back, you missed a great opportunity. ADMD is doing just fine, our girl Heather will guide this thru the FDA approval process quickly.
No rush to buy shares on this. Posters are right who say this is dead money for months. I'll buy at 3 cents.
ADMD climbing back, Heather Rosecrans will lead the charge.
Heather Rosecrans, ADMD senior consultant.